Skip to main content
SpringerLink
Log in

Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Multidrug resistance-associated protein 2 (MRP2) is a multi-specific organic anion transporter predominantly expressed in the canalicular membrane of hepatocytes, epithelial cells from gallbladder and apical membranes of proximal tubular kidney epithelium whereas multidrug resistance-associated protein 3 (MRP3) is present in the basolateral membrane of hepatocytes and cholangiocytes. This study aims to detect the expression of these transporters in hepatocellular carcinoma (HCC) and in cholangiocarcinoma (CC), searching for evidences for future studies on differential diagnosis and on clinical essays. The immunohistochemical reactivity (IHC) of these transporters was assessed in tissue microarrays of 80 HCC and 56 CC cases using monoclonal antibodies and compared with anatomopathological (AP) variables. The positivity of MRP2 was observed in 92.3% of HCC and in 96.3% of CC. The detection of high MRP2 expression in HCC was not significantly different (p > 0.05) according to the size, number of nodules architectural pattern and growth pattern of HCC and CC. Regarding histological grades, 22/22 well moderately differentiated HCC versus 50/56 poorly differentiated HCC were positive for MRP2. A trend for lower expression in poor differentiation HCC was found. And 50/50 well/moderately differentiated CC versus 2/4 poorly/undifferentiated CC were positive for MRP2. This result showed a reduced expression (p = 0,0004) in poorly differentiated CC. MRP3 positivity was observed in 18.8% of HCC and was not significantly different according to AP parameters. MRP3 was expressed in 44.5% CC, with a trend for lower expression in less differentiated CC and significantly lower rates in the ductular histological subtype (p = 0.023). The high expression of MRP2 in HCC and in CC is conserved regardless most of the anatomopathological parameters, except for a trend of lower expression in less differentiated HCC and CC. The observation of lower MRP3 expression in less differentiated CC and, especially, in the histological subtype with expression of hepatic progenitor cell phenotypes leads to future opportunities to evaluate the expression of this marker in cholangiocarcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Hum Genomics 3:281–290. https://doi.org/10.1186/1479-7364-3-3-281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Stefková J, Poledne R, Hubácek JA (2004) ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res 53(3):235–243

    PubMed  Google Scholar 

  3. Tarling EJ, de Aguiar Vallim TQ, Edwards PA (2013) Role of ABC transporters in lipid transport and human disease. Trends Endocrinol Metab 24(7):342–350. https://doi.org/10.1016/j.tem.2013.01.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK (2015) Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Histopathology 66(4):598–602. https://doi.org/10.1111/his.12601

    Article  PubMed  Google Scholar 

  5. Nguyen T, Phillips D, Jain D, Torbenson M, Wu T-T, Yeh MM et al (2015) Comparison of 5 immunohistochemical markers of hepatocellular differentiation for the diagnosis of hepatocellular carcinoma. Arch Pathol Lab Med 139(8):1028–1034. https://doi.org/10.5858/arpa.2014-0479-OA

    Article  CAS  PubMed  Google Scholar 

  6. Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y et al (2016) BSEP and MDR3 – useful immunohistochemical markers to discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas. Am J Surg Pathol 40(5):689–696. https://doi.org/10.1097/PAS.0000000000000585

    Article  PubMed  Google Scholar 

  7. Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83(2):633–671. https://doi.org/10.1152/physrev.00027.2002

    Article  CAS  PubMed  Google Scholar 

  8. ABCC2: ATP-binding cassette, sub-family C (CFTR/MRP), member 2. [Internet]. The Human Protein Atlas. 2017. http://www.proteinatlas.org/ENSG00000023839-ABCC2/tissue. Accessed 31 Jan 2017

  9. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M et al (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56(18):4124–4129

    CAS  PubMed  Google Scholar 

  10. Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C et al (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370(1):153–164. https://doi.org/10.1016/j.canlet.2015.10.010

    Article  CAS  PubMed  Google Scholar 

  11. Nies AT, Konig J, Cui Y, Brom M, Spring H, Keppler D (2002) Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). Eur J Biochem 269(7):1866–1876. https://doi.org/10.1007/s00424-006-0109-y

    Article  CAS  PubMed  Google Scholar 

  12. Jedlitschky G, Hoffmann U, Kroemer HK (2006) Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol 2(3):351–366

    Article  CAS  Google Scholar 

  13. Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 10:1803–1823. https://doi.org/10.1517/17425255.2.3.351

    Article  Google Scholar 

  14. Erlinger S, Arias IM, Dhumeaux D (2014) Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology 146(7):1625–1638. https://doi.org/10.1053/j.gastro.2014.03.047

    Article  CAS  PubMed  Google Scholar 

  15. Keppler D (2014) The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos 42(4):561–565. https://doi.org/10.1124/dmd.113.055772

    Article  CAS  PubMed  Google Scholar 

  16. Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ et al (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A 96(12):6914–6919. https://doi.org/10.1073/pnas.96.12.6914

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J et al (2000) Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 60(18):5269–5277

    CAS  PubMed  Google Scholar 

  18. Klaassen CD, Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62(1):1–96. https://doi.org/10.1124/pr.109.002014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. ABCC3: ATP-binding cassette, sub-family C (CFTR/MRP), member 3 [Internet]. The Human Protein Atlas. 2017. http://www.proteinatlas.org/ENSG00000108846-ABCC3/tissue. Accessed 31 Jan 2017

  20. ABCC3: ATP-binding cassette, sub-family C (CFTR/MRP), member 3 [Internet]. GenAtlas - Universite Paris Descartes. 2017. http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=ABCC3. Accessed 31 Jan 2017

  21. König J, Rost D, Cui Y, Keppler D (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29(4):1156–1163. https://doi.org/10.1002/hep.510290404

    Article  PubMed  Google Scholar 

  22. Ballatori N, Hammond CL, Cunningham JB, Krance SM, Marchan R (2005) Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 204(3):238–255. https://doi.org/10.1016/j.taap.2004.09.008

    Article  CAS  PubMed  Google Scholar 

  23. Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V et al (2005) Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68(1):160–168. https://doi.org/10.1124/mol.104.010587

    Article  CAS  PubMed  Google Scholar 

  24. Halilbasic E, Claudel T, Trauner M (2013) Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58(1):155–168. https://doi.org/10.1016/j.jhep.2012.08.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sodani K, Patel A, Kathawala RJ, Chen Z-S (2012) Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer 31(2):58–72. https://doi.org/10.5732/cjc.011.10329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rau S, Autschbach F, Riedel HD, Konig J, Kulaksiz H, Stiehl A et al (2008) Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas. Eur J Clin Investig 38(2):134–142. https://doi.org/10.1111/j.1365-2362.2007.01916.x

    Article  CAS  Google Scholar 

  27. Tomonari T, Takeishi S, Taniguchi T, Tanaka T, Tanaka H, Fujimoto S et al (2016) MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma. Oncotarget 7(6):7207–7215. https://doi.org/10.18632/oncotarget.6889

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K et al (2005) Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int (2):367–379. https://doi.org/10.1111/j.1478-3231.2005.01033.x

    Article  CAS  Google Scholar 

  29. Nies AT, König J, Pfannschmidt M, Klar E, Hofmann WJ, Keppler D (2001) Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94(4):492–499. https://doi.org/10.1111/j.1478-3231.2005.01033.x

    Article  CAS  PubMed  Google Scholar 

  30. Borght VS, Libbrecht L, Blokzijl H, Faber NK, Moshage H, Aerts R et al (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207(4):471–482. https://doi.org/10.1002/path.1852

    Article  CAS  Google Scholar 

  31. Apte U, Krisnamurthy P (2010) Molecular pathology of liver diseases. In: Monga SPS (ed) Molecular pathology of liver diseases 1st edn. Springer, Boston, pp 147–164

  32. Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Takamura M et al (2010) Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep 4:965–972. https://doi.org/10.3892/ijmm.2012.1173

    Article  CAS  Google Scholar 

  33. Atilano-Roque A, Roda G, Fogueri U, Kiser JJ, Joy MS (2016) Effect of disease pathologies on transporter expression and function. J Clin Pharmacol 56(Suppl7):S205–S221. https://doi.org/10.1002/jcph.768

    Article  CAS  PubMed  Google Scholar 

  34. Buettner S, van Vugt JLA, IJzermans J, Groot Koerkamp B (2017) Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther 10:1131–1142. https://doi.org/10.2147/OTT.S93629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29(2):277–293. https://doi.org/10.1016/j.bpg.2015.02.006

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Núcleo de Anatomia Patológica, Centro de Patologia, Instituto Adolfo Lutz, São Paulo, Brazil

    Cinthya Santos Cirqueira

  2. Departamento de Patologia, Laboratório de Investigação Médica LIM-14, Universidade de São Paulo, São Paulo, Brazil

    Cinthya Santos Cirqueira, Aloisio Sousa Felipe-Silva, Alda Wakamatsu, Lidiane Vieira Marins, Eziel Cavalcanti Rocha, Evandro Sobroza de Mello & Venâncio Avancini Ferreira Alves

Authors
  1. Cinthya Santos Cirqueira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aloisio Sousa Felipe-Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alda Wakamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lidiane Vieira Marins
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eziel Cavalcanti Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evandro Sobroza de Mello
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Venâncio Avancini Ferreira Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cinthya Santos Cirqueira.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest with respect to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cirqueira, C.S., Felipe-Silva, A.S., Wakamatsu, A. et al. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma. Pathol. Oncol. Res. 25, 1363–1371 (2019). https://doi.org/10.1007/s12253-018-0386-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0386-8

Keywords

Search

Navigation